Local ablation for solid tumor liver metastases: Techniques and treatment efficacy

Cancer Control

Volumn 23, Issue 1, 2016, Pages 30-35

  Wong, Joyce ^a   Cooper, Amanda ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ABLATION THERAPY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CRYOTHERAPY; DISEASE FREE SURVIVAL; DRUG EFFECT; HUMAN; INTERMETHOD COMPARISON; IRREVERSIBLE ELECTROPORATION; LIFE EXPECTANCY; LIVER METASTASIS; METASTATIC COLORECTAL CANCER; MICROWAVE THERAPY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; RADIOFREQUENCY ABLATION; SURVIVAL TIME; SYSTEMIC THERAPY; TREATMENT PLANNING; TUMOR ABLATION; ADVERSE EFFECTS; BREAST TUMOR; CATHETER ABLATION; COLORECTAL TUMOR; ELECTROPORATION; FEMALE; LIVER NEOPLASMS; MICROWAVE RADIATION; NEUROENDOCRINE TUMOR; PATHOLOGY; PROCEDURES; SECONDARY; TEMPERATURE; THERAPEUTIC USE; TREATMENT OUTCOME;

BREAST NEOPLASMS; CATHETER ABLATION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CRYOTHERAPY; DISEASE-FREE SURVIVAL; ELECTROPORATION; FEMALE; HUMANS; LIVER NEOPLASMS; MICROWAVES; NEUROENDOCRINE TUMORS; TEMPERATURE; TREATMENT OUTCOME;

EID: 84960408982     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327481602300106     Document Type: Article

References (48)

1. Dexiang Z, Li R, Ye W, et al. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases. Ann Surg Oncol. 2012;19(9):2860-2868.
2. O’Rourke TR, Tekkis P, Yeung S, et al. Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol. 2008;15(1):207-218.
3. Antoniou A, Lovegrove RE, Tilney HS, et al. Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases. Surgery. 2007;141(1):9-18.
4. Bai H, Huangz X, Jing L, et al. The effect of radiofrequency ablation vs. liver resection on survival outcome of colorectal liver metastases (CRLM): a meta-analysis. Hepatogastroenterology. 2015;62(138):373-377.
5. Livraghi T, Festi D, Monti F, et al. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology. 1986;161(2):309-312.
6. Ravikumar TS, Kane R, Cady B, et al. A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg. 1991;126(12):1520-1524.
7. Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in treating colorectal metastases. Cancer. 1995;76(2):210-214.
8. Sibille A, Prat F, Chapelon JY, et al. Extracorporeal ablation of liver tissue by high-intensity focused ultrasound. Oncology. 1993;50(5):375-379.
9. Dutta P, Montes M, Gage AA. Experimental hepatic cryosurgery. Cryobiology. 1977;14(5):598-608.
10. Charnley RM, Doran J, Morris DL. Cryotherapy for liver metastases: a new approach. Br J Surg. 1989;76(10):1040-1041.
11. Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in the treatment of unresectable metastases. Surg Oncol. 1995;4(5):231-236.
12. Ross WB, Horton M, Bertolino P, et al. Cryotherapy of liver tumours-a practical guide. HPB Surg. 1995;8(3):167-173.
13. Buscarini L, Rossi S. Technology for radiofrequency thermal ablation of liver tumors. Semin Laparosc Surg. 1997;4(2):96-101.
14. Vogl TJ, Farshid P, Naguib NN, et al. Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. Radiol Med. 2014;119(7):451-461.
15. Zorbas G, Samaras T. A study of the sink effect by blood vessels in radiofrequency ablation. Comput Biol Med. 2015;57:182-186.
16. Lubner MG, Brace CL, Ziemlewicz TJ, et al. Microwave ablation of hepatic malignancy. Semin Intervent Radiol. 2013;30(1):56-66.
17. de Baere T, Deschamps F. New tumor ablation techniques for cancer treatment (microwave, electroporation). Diagn Interv Imaging. 2014;95(7-8):677-682.
18. Dodd GD III, Napier D, Schoolfield JD, et al. Percutaneous radio-frequency ablation of hepatic tumors: postablation syndrome. AJR Am J Roentgenol. 2005;185(1):51-57.
19. Wah TM, Arellano RS, Gervais DA, et al. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology. 2005;237(3):1097-1102.
20. Carrafiello G, Laganà D, Ianniello A, et al. Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works. Australas Radiol. 2007;51(6):550-554.
21. Andreano A, Galimberti S, Franza E, et al. Percutaneous microwave ablation of hepatic tumors: prospective evaluation of postablation syndrome and postprocedural pain. J Vasc Interv Radiol. 2014;25(1):97-105.e1-2.
22. Takaki H, Yamakado K, Nakatsuka A, et al. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience. AJR Am J Roentgenol. 2013;200(3):658-664.
23. Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004;239(4):450-458.
24. Lahat E, Eshkenazy R, Zendel A, et al. Complications after percutaneous ablation of liver tumors: a systematic review. Hepatobiliary Surg Nutr. 2014;3(5):317-323.
25. Livraghi T, Meloni F, Solbiati L, et al; Collaborative Italian Group Using AMICA system. Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol. 2012;35(4):868-874.
26. Miller L, Leor J, Rubinsky B. Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat. 2005;4(6):699-705.
27. Cannon R, Ellis S, Hayes D, et al. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol. 2013;107(5):544-549.
28. Dunki-Jacobs EM, Philips P, Martin RC II. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model. Br J Surg. 2014;101(9):1113-1121.
29. Scheffer HJ, Nielsen K, van Tilborg AA, et al. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLD-FIRE-I ablate-and-resect study. Eur Radiol. 2014;24(10):2467-2475.
30. Scheffer HJ, Nielsen K, de Jong MC, et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol. 2014;25(7):997-1011.
31. Thomson KR, Cheung W, Ellis SJ, et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol. 2011;22(5):611-621.
32. Wong SL, Mangu PB, Choti MA, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010;28(3):493-508.
33. Burdio F, Mulier S, Navarro A, et al. Influence of approach on outcome in radiofrequency ablation of liver tumors. Surg Oncol. 2008;17(4):295-299.
34. Kitchin D, Lubner M, Ziemlewicz T, et al. Microwave ablation of malignant hepatic tumours: intraperitoneal fluid instillation prevents collateral damage and allows more aggressive case selection. Int J Hyperthermia. 2014;30(5):299-305.
35. Ruers T, Punt C, Van Coevorden F, et al; EORTC Gastro-Intestinal Tract Cancer Group, Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO) and the National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG). Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23(10):2619-2626.
36. Mulier S, Ruers T, Jamart J, et al. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg. 2008;25(6):445-460.
37. Weng M, Zhang Y, Zhou D, et al. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One. 2012;7(9):e45493.
38. Khajanchee YS, Hammill CW, Cassera MA, et al. Hepatic resection vs minimally invasive radiofrequency ablation for the treatment of colorectal liver metastases: a Markov analysis. Arch Surg. 2011;146(12):1416-1423.
39. Tanis E, Nordlinger B, Mauer M, et al. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. Eur J Cancer. 2014;50(5):912-919.
40. Shibata T, Niinobu T, Ogata N, et al. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer. 2000;89(2):276-284.
41. Evrard S, Rivoire M, Arnaud J, et al. Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection. Br J Surg. 2012;99(4):558-565.
42. Gillams A, Goldberg N, Ahmed M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontieres meeting 2013. Eur Radiol. 2015;25(12):3438-3454.
43. Leung U, Kuk D, D’Angelica MI, et al. Long-term outcomes following microwave ablation for liver malignancies. Br J Surg. 2015;102(1):85-91.
44. Lorentzen T, Skjoldbye BO, Nolsoe CP. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients. Ultraschall Med. 2011;32(5):492-496.
45. Hosein PJ, Echenique A, Loaiza-Bonilla A, et al. Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system. J Vasc Interv Radiol. 2014;25(8):1233-1239.e1232.
46. Ta şçi Y, Aksoy E, Taşkın HE, et al. A comparison of laparoscopic radiofrequency ablation versus systemic therapy alone in the treatment of breast cancer metastasis to the liver. HPB (Oxford). 2013;15(10):789-793.
47. Pawlik TM, Vauthey JN, Abdalla EK, et al. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg. 2006;141(6):537-544.
48. Yamakado K, Nakatsuka A, Takaki H, et al. Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer. J Vasc Interv Radiol. 2005;16(12):1747-1751.